HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Tekla Life Sciences Investors (HQL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -2.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.1 | – | – | – | – | 0.0 | – | 0.0 | – | – | – | -2.3 | |
| -142 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | -0.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | – | – | 25 | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | 32 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | -32 | |
| 0.0 | – | – | – | – | 1.1 | – | 0.0 | 0.0 | 0.0 | – | 0.1 | |
| -0.1 | – | – | – | – | 0.0 | – | 0.0 | – | – | – | -2.3 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.